Showing results (1-10 of 1,123) with videos related to
Sort By:
Pageof 113
Expert Review of Clinical Immunology|July 19, 2016
Baricitinib for the treatment of rheumatoid arthritisSatoshi Kubo, Shingo Nakayamada, Yoshiya TanakaExpert Opinion on Investigational Drugs|April 4, 2023
JAK inhibitors for rheumatoid arthritisSatoshi Kubo, Shingo Nakayamada, Yoshiya TanakaExpert Review of Clinical Immunology|April 17, 2019
Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 updateSatoshi Kubo, Shingo Nakayamada, Yoshiya TanakaModern Rheumatology|October 19, 2018
Immunophenotype involved in IgG4-related diseaseSatoshi Kubo, Shingo Nakayamada, Yoshiya TanakaExpert Opinion on Pharmacotherapy|October 4, 2016
Chemical JAK inhibitors for the treatment of rheumatoid arthritisShingo Nakayamada, Satoshi Kubo, Shigeru Iwata, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 1, 2016
Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid ArthritisShingo Nakayamada, Satoshi Kubo, Shigeru Iwata, et al.Clinical Immunology (Orlando, Fla.)|August 10, 2017
B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosusYoshiya Tanaka, Satoshi Kubo, Shigeru Iwata, et al.Seminars in Arthritis and Rheumatism|May 14, 2019
Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases✰Yoshiya Tanaka, Satoshi Kubo, Ippei Miyagawa, et al.Frontiers in Immunology|June 11, 2026
Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosusMasanobu Ueno, Satoshi Kubo, Yasuyuki Todoroki, et al.Clinical and Experimental Rheumatology|May 19, 2017
Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritisShunsuke Fukuyo, Shingo Nakayamada, Shigeru Iwata, et al.Pageof 113